Caliway Biopharmaceuticals Logo

Caliway Biopharmaceuticals

🇹🇼
6919
TW0006919004

Caliway Biopharmaceuticals, headquartered in Taiwan, is an innovative pharmaceutical company specializing in the development of novel therapeutics. The company focuses on the research and clinical testing of medical solutions aimed at treating various dermatological and oncological diseases.

Next Quarterly Earnings

Wednesday, November 11, 2026
CW 46
Pre-Market
In 76 days

Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

Quiet period starts on October 14, 2026

Stock Price

Frequently asked questions

When will Caliway Biopharmaceuticals report its next quarterly earnings?

Caliway Biopharmaceuticals is scheduled to report its next quarterly earnings on 11/11/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

When did Caliway Biopharmaceuticals last report quarterly earnings?

Caliway Biopharmaceuticals last reported quarterly earnings on 4/10/2026 (Q1 2026). Earnings per share (EPS) came in at -0.22 TWD.

How often has Caliway Biopharmaceuticals beaten expectations?

Caliway Biopharmaceuticals has beaten analyst EPS estimates in 1 of its last 5 evaluated quarters (beat rate: 20%).

How do I add the Caliway Biopharmaceuticals earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-NT$0.25
Actual:
Q1 2026
Missed
Estimate:$2.93
Actual:-$0.14
Difference:-$3.07
Q1 2026
Met
Estimate:-NT$0.22
Actual:-NT$0.22
Difference:+NT$0.00
Price reaction (1 day):-1.3 %
Price reaction (7 days):-4.9 %
Q4 2025
Missed
Estimate:-NT$0.17
Actual:-NT$0.23
Difference:-NT$0.06
Price reaction (1 day):-0.3 %
Price reaction (7 days):-8.8 %
Q2 2025
Beat
Estimate:-$0.19
Actual:-$0.01
Difference:+$0.18
Q1 2025
Missed
Estimate:-$0.13
Actual:-$0.16
Difference:-$0.03

Earnings statistics

Estimates vs. results

1/5
Quarters above estimates
20%
Beat rate
+0.2%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Caliway Biopharmaceuticals
Ticker Symbol
6919
ISIN
TW0006919004
Country
🇹🇼
Taiwan
Sector